Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

Lorenza Rimassa, Stephen L. Chan, Bruno Sangro, George Lau, Masatoshi Kudo, Maria Reig, Valeriy Breder, Min-Hee Ryu, Yuriy Ostapenko, Wattana Sukeepaisarnjaroen, Maria Varela, David Tougeron, Oxana V. Crysler, Mohamed Bouattour, Tu Van Dao, Vincent C. Tam, Adilson Faccio, Junji Furuse, Long-Bin Jeng, Yoon Koo Kang, Robin K. Kelley, Michael J. Paskow, Di Ran, Ioannis Xynos, John F. Kurland, Alejandra Negro, Ghassan K. Abou-Alfa

Open source

DOI: 10.1016/j.jhep.2025.03.033
Published: 2025-10
Container: Journal of Hepatology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2025.03.033,
  title = {Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC},
  author = {Lorenza Rimassa and Stephen L. Chan and Bruno Sangro and George Lau and Masatoshi Kudo and Maria Reig and Valeriy Breder and Min-Hee Ryu and Yuriy Ostapenko and Wattana Sukeepaisarnjaroen and Maria Varela and David Tougeron and Oxana V. Crysler and Mohamed Bouattour and Tu Van Dao and Vincent C. Tam and Adilson Faccio and Junji Furuse and Long-Bin Jeng and Yoon Koo Kang and Robin K. Kelley and Michael J. Paskow and Di Ran and Ioannis Xynos and John F. Kurland and Alejandra Negro and Ghassan K. Abou-Alfa},
  year = {2025},
  journal = {Journal of Hepatology},
  doi = {10.1016/j.jhep.2025.03.033},
  url = {https://doi.org/10.1016/j.jhep.2025.03.033}
}

RIS

TY  - JOUR
TI  - Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
AU  - Lorenza Rimassa
AU  - Stephen L. Chan
AU  - Bruno Sangro
AU  - George Lau
AU  - Masatoshi Kudo
AU  - Maria Reig
AU  - Valeriy Breder
AU  - Min-Hee Ryu
AU  - Yuriy Ostapenko
AU  - Wattana Sukeepaisarnjaroen
AU  - Maria Varela
AU  - David Tougeron
AU  - Oxana V. Crysler
AU  - Mohamed Bouattour
AU  - Tu Van Dao
AU  - Vincent C. Tam
AU  - Adilson Faccio
AU  - Junji Furuse
AU  - Long-Bin Jeng
AU  - Yoon Koo Kang
AU  - Robin K. Kelley
AU  - Michael J. Paskow
AU  - Di Ran
AU  - Ioannis Xynos
AU  - John F. Kurland
AU  - Alejandra Negro
AU  - Ghassan K. Abou-Alfa
PY  - 2025
JO  - Journal of Hepatology
DO  - 10.1016/j.jhep.2025.03.033
UR  - https://doi.org/10.1016/j.jhep.2025.03.033
ER  -

APA

Rimassa, L., Chan, S. L., Sangro, B., Lau, G., Kudo, M., Reig, M., Breder, V., Ryu, M., Ostapenko, Y., Sukeepaisarnjaroen, W., Varela, M., Tougeron, D., Crysler, O. V., Bouattour, M., Dao, T. V., Tam, V. C., Faccio, A., Furuse, J., Jeng, L., Kang, Y. K., Kelley, R. K., Paskow, M. J., Ran, D., Xynos, I., Kurland, J. F., Negro, A., & Abou-Alfa, G. K. (2025). Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2025.03.033

Source records

crossref · retrieved 2026-09-25T21:52:09.395Z